Actively Recruiting
Improving Engagement in Alcohol Treatment for Adults with Alcohol-Related Liver Disease Using the ENGAGE-ALD App and Supportive Interventions
Led by Henry Ford Health System · Updated on 2026-02-03
268
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether providing patients with alcohol-related liver disease tailored alcohol use treatment options can increase their participation in treatment and correct any misconceptions they may have. This trial focuses on adults diagnosed with alcohol-related liver disease who have used alcohol in the past six months and have not recently received alcohol treatment. The study aims to improve engagement with alcohol use disorder treatment through behavioral interventions. Participants will be randomly assigned to receive the ENGAGE-ALD app, a behavioral application designed to improve knowledge about alcohol use and match patients to preferred alcohol treatment options based on their preferences. After three months, those who do not engage in treatment will be re-randomized to receive either a Treatment Facilitation bundle, which includes a barriers survey and a virtual coaching session, or Enhanced Usual Care, which provides standard hepatology care plus educational materials about alcohol treatment resources. The treatment period lasts six months, divided into two three-month stages depending on engagement. Participants will be assessed at the start and after six months for alcohol treatment engagement, alcohol use frequency, heavy drinking days, and liver health through laboratory tests and clinical scores. The study involves completing behavioral interventions, surveys, and follow-up assessments. Participants will have access to smartphones or computers for follow-up if needed. The primary measure is alcohol treatment engagement, alongside secondary outcomes related to alcohol use and liver health changes throughout the study.
CONDITIONS
Brief Title
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
Research Team
M
Matthew Melican
J
Jessica Mellinger, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here